The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 1.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading oversold. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 6%. The street (1 analysts) rates it none, with a mean price target of $678.
Boubyan Petrochemical Company K.S.C.P.
BPCC.KW · KUW · USD · Market cap $352M
Boubyan Petrochemical Company K.S.C.P.
FAIL · Does not pass the screenPrice as of 12 Nov 2026Daily close, not a live quoteLast reviewed 5 days ago
Screened 2026-11-12 · the tape above runs as of 04:19 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price685.00 USD at the 12 Nov 2026 close
- Fair value342.50. Our model only; only one analyst covers it, too few to cross-check it.
- Our value readOvervalued vs our fair value, as of 12 Nov 2026
- Our regime readDistribution, as of 15 Nov 2026
- Ethical screenDoes not pass
- Last reviewed12 Nov 2026 (5 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $342.50 to $371.46, base estimate $342.50 (screen dated 2026-11-12).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
Boubyan Petrochemical Company K.S.C.P. holds its Distribution at $685.00. Elevated stress, defensive posture warranted, held for 14 days.
| Phase | Distribution · caution |
| Quantitative state | Elevated stress, defensive posture warranted, held for 14 days |
| Price at the screen | $685.00 |
| Valuation | 14,500.00 trailing · 10,357.14 forward price to earnings |
| Values screen | FAIL |
| Beta | 0.25 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 47.57% | Below 33% | Interest-bearing debt is 47.6% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 40.51% | Below 33% | Interest-bearing cash and securities are 40.5% of assets, above the one-third limit. | Fail |
| Receivables | 18.72% | Below 49% | Money owed to the company is 18.7% of assets, under the 49% limit. | Pass |
| Revenue purity | 2.70% | Below 5% | Only 2.7% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Boubyan Petrochemical Company K.S.C.P.'s business is in a permissible area, but its interest-bearing debt is about 48% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when BPCC.KW's ethical verdict changes
Today BPCC.KW does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our model only; only one analyst covers it, too few to cross-check it.
Our analysis reads Overvalued vs our fair value, as of 12 Nov 2026: it trades above our $342.50 fair value estimate, strong competitive moat, 4.00% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-12 screen. The gold marker is the market price at the same screen. The price runs 100.0% above the base estimate.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & ProjectionsWhere our models see it going: fair-value estimate $342.50, with a range of $342.50 to $371.46, dated to the 2026-11-12 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it gives us pause
At 10,357.1x forward earnings, the price already runs ahead of the business. It trades 100% above our $342.50 fair value, so you would be buying at a premium, not a discount. The strong moat is real, but quality alone does not make an expensive price cheap.
| Forward P/E | 10,357.1xexpensive even after accounting for its growth |
| Trailing P/E | 14,500.0xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 0.05 |
| EPS, forward | 0.07 |
| Revenue growth | +4.0%slow but positive growth |
| Profit margin | 25.0%healthy profit margins |
| Return on equity | 12.1%a solid return on shareholder capital |
| FCF yield | 4.62% |
| Dividend yield | 6.06% |
| Debt to equity | 1.13a meaningful debt load worth watching |
| Current ratio | 1.69healthy short-term liquidity |
| Beta | 0.25barely tracks the market's swings |
| 52-week range | 519.05 - 670.48 |
| Moat | STRONG |
| Market cap | $352M |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; its business and earnings are exposed to Kuwait and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeBPCC.KW trades on KUW (the company is based in Kuwait). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 6.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 6%. The street (1 analysts) rates it none, with a mean price target of $678.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 6%. The street (1 analysts) rates it none, with a mean price target of $678.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 6%. The street (1 analysts) rates it none, with a mean price target of $678.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 15.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 6%. The street (1 analysts) rates it none, with a mean price target of $678. Since the last review it its composite score eased.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 6%. The street (1 analysts) rates it none, with a mean price target of $678.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 3.5% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 6%. The street (1 analysts) rates it none, with a mean price target of $678.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 6%. The street (1 analysts) rates it none, with a mean price target of $678.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $626.00 | +8.0% | · | $1,080 | +8.0% |
| 2 months | $581.00 | +16.4% | · | $1,164 | +16.4% |
| 3 months | $566.00 | +19.4% | · | $1,194 | +19.4% |
| 6 months | $609.00 | +11.0% | · | $1,110 | +11.0% |
| 1 year | $696.96 | -3.0% | $40.00 | $1,027 | +2.7% |
| 2 years | $674.90 | +0.2% | $100.00 | $1,150 | +15.0% |
| 3 years | $796.82 | -15.2% | $160.00 | $1,049 | +4.9% |
| 5 years | $909.68 | -25.7% | $275.00 | $1,045 | +4.5% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever BPCC.KW does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.